Fundamentals Hub
TCBPY TC BioPharm (Holdings) plc
TCBPY financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
Filer Category
Non-accelerated filer<br>Emerging growth company
Entity Type
Operating
Public Float
$3.10M (Jun 2023)
Industry (SIC)
2836 Biological Products, (No Diagnostic Substances)
Incorporated
X0
Fiscal Year End
December (1231)
Phone
01414337557
EIN
000000000
Headquarters
HOLYTOWN, X0, ML1 4WR
Former Names:
TC BioPharm (Holdings) Ltd (2021–2021)
▼ Key Metrics (FY 2024)
As of Dec 31, 2024Financials
Revenue
-
Net Income
$-15.30M
Total Assets
-
Total Equity
$3.80M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-402.6%
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2024 📄 |
|---|---|
| Income Statement | |
| REVENUE | |
| OPERATING EXPENSES | |
| NON-OPERATING INCOME / EXPENSE | |
| Net Income | $-15.30M |
| PER SHARE & SUPPLEMENTAL | |
| Diluted Shares | 377.47M |
| Balance Sheet | |
| ASSETS | |
| Cash & Equivalents | $1.50M |
| LIABILITIES | |
| EQUITY | |
| Total Equity | $3.80M |
| SUPPLEMENTAL | |
| Shares Outstanding | 1.99B |
| Check: A − (L + E + NCI) | $-3.80M |
| Cash Flow Statement | |
| Cash from Operations | $-15.80M |
| Capital Expenditures | - |
| Cash from Investing | - |
| Cash from Financing | - |
| Free Cash Flow | - |
| Beginning Cash (CFS) | - |
| Net Change in Cash | - |
| Effect of FX on Cash | - |
| Calculated Ending Cash | - |
| Cash per BS | $1.50M |
| Cash scope difference (CFS − BS) | - |
| Cash per CFS | $1.50M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is TC BioPharm (Holdings) plc profitable?
No. TC BioPharm (Holdings) plc reported $-15.30M in net income for fiscal year 2024. Profitability data is based on the company's most recent annual report filed with the SEC.